Feasibility, Reliability, and Clinical Validity of Eye Tracking and Pupillometry as an Outcome Measure for Clinical Trials in Fragile X Syndrome (FXS)

被引：0
|
作者：
Scaggs, F.
Farzin, F.
Hervey, C.
Hessl, D.
Berry-Kravis, E.
机构：
来源：
ANNALS OF NEUROLOGY | 2010年 / 68卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S103 / S103
页数：1
相关论文
共 50 条
  • [21] PARENT RATINGS OF ABILITY TO CONSENT FOR CLINICAL TRIALS IN FRAGILE X SYNDROME
    Bailey, D.
    Raspa, M.
    Wheeler, A.
    VALUE IN HEALTH, 2013, 16 (07) : A603 - A604
  • [22] Functional MRI as a Biomarker for AD Clinical Trials: Validity, Reliability, Power Estimates & Tracking Clinical Measures
    Atri, Alireza
    Sreenivasan, Aishwarya
    Diamond, Eli
    Rentz, Dorene
    Locascio, Joseph
    Sperling, Reisa
    NEUROLOGY, 2011, 76 (09) : A190 - A191
  • [23] Assessing the validity and reliability of a simple activity participation measure for rheumatoid arthritis clinical trials
    Li, T.
    Wells, G.
    Tugwell, P.
    VALUE IN HEALTH, 2008, 11 (03) : A266 - A266
  • [24] Insights into GABAAergic system deficits in fragile X syndrome lead to clinical trials
    Braat, Sien
    Kooy, R. Frank
    NEUROPHARMACOLOGY, 2015, 88 : 48 - 54
  • [25] Fragile X syndrome clinical trials: exploring parental decision-making
    D'Amanda, C. S.
    Peay, H. L.
    Wheeler, A. C.
    Turbitt, E.
    Biesecker, B. B.
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2019, 63 (08) : 926 - 935
  • [26] Challenges in Conducting Clinical Trials for Pharmacotherapies in Fragile X Syndrome: Lessons Learned
    Harkins C.M.
    Dominick K.C.
    Wink L.K.
    Pedapati E.V.
    Shaffer R.C.
    Fitzpatrick S.E.
    Davenport M.H.
    Sweeney J.A.
    Erickson C.A.
    Pharmaceutical Medicine, 2017, 31 (4) : 235 - 244
  • [27] Interexaminer reliability and clinical validity of the temporomandibular index: A new outcome measure for temporomandibular disorders
    Pehling, J
    Schiffman, E
    Look, J
    Shaefer, J
    Lenton, P
    Fricton, J
    JOURNAL OF OROFACIAL PAIN, 2002, 16 (04): : 296 - 304
  • [28] Parental Perspectives on Pharmacological Clinical Trials: a Qualitative Study in Down Syndrome and Fragile X Syndrome
    Reines, Victoria
    Charen, Krista
    Rosser, Tracie
    Eisen, Arri
    Sherman, Stephanie L.
    Visootsak, Jeannie
    JOURNAL OF GENETIC COUNSELING, 2017, 26 (06) : 1333 - 1340
  • [29] Validity of a condition specific outcome measure for fragile X syndrome: the Aberrant Behaviour Checklist-utility index
    Raspa, M.
    Sacco, P.
    Candrilli, S. D.
    Bishop, E.
    Petrillo, J.
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2016, 60 (09) : 844 - 855
  • [30] Human EEG Biomarker Use in Fragile X Syndrome and Related Disorders Clinical Trials
    Erickson, Craig
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S99 - S99
12345